Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Frank I. Tarazi, PH.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Calabrese F, Tarazi FI, Racagni G, Riva MA. The role of dopamine D3 receptors in the mechanism of action of cariprazine. CNS Spectr. 2019 Apr 23; 1-9. PMID: 31010452.
    Citations:    
  2. Gonda X, Sharma SR, Tarazi FI. Vortioxetine: a novel antidepressant for the treatment of major depressive disorder. Expert Opin Drug Discov. 2019 Jan; 14(1):81-89. PMID: 30457395.
    Citations:    Fields:    
  3. Choi YK, Tarazi FI. Long-Term Effects of Iloperidone on Cerebral Serotonin and Adrenoceptor Subtypes. J Mol Neurosci. 2018 Sep; 66(1):59-67. PMID: 30091081.
    Citations:    Fields:    Translation:Animals
  4. Kee Choi Y, Tarazi FI. Long-term effects of iloperidone on cerebral dopamine receptor subtypes. Synapse. 2018 Jun 23; e22039. PMID: 29935022.
    Citations:    Fields:    
  5. Tayeb HO, Murad HA, Rafeeq MM, Tarazi FI. Pharmacotherapy of schizophrenia: toward a metabolomic-based approach. CNS Spectr. 2019 Jun; 24(3):281-286. PMID: 29866209.
    Citations:    Fields:    
  6. Sharma SR, Gonda X, Tarazi FI. Autism Spectrum Disorder: Classification, diagnosis and therapy. Pharmacol Ther. 2018 10; 190:91-104. PMID: 29763648.
    Citations: 2     Fields:    
  7. Sahli ZT, Tarazi FI. Pimavanserin: novel pharmacotherapy for Parkinson's disease psychosis. Expert Opin Drug Discov. 2018 01; 13(1):103-110. PMID: 29047301.
    Citations: 2     Fields:    Translation:HumansAnimals
  8. Choi YK, Gardner MP, Tarazi FI. Developmental effects of antipsychotic drugs on serotonin receptor subtypes. Synapse. 2017 Oct; 71(10):e21988. PMID: 28597539.
    Citations:    Fields:    
  9. Heal DJ, Hallam M, Prow M, Gosden J, Cheetham S, Choi YK, Tarazi F, Hutson P. Dopamine and µ-opioid receptor dysregulation in the brains of binge-eating female rats - possible relevance in the psychopathology and treatment of binge-eating disorder. J Psychopharmacol. 2017 06; 31(6):770-783. PMID: 28376679.
    Citations:    Fields:    Translation:Animals
  10. Dimopoulou T, Tarazi FI, Tsapakis EM. Clinical and therapeutic role of mentalization in schizophrenia-a review. CNS Spectr. 2017 12; 22(6):450-462. PMID: 28219455.
    Citations: 1     Fields:    
  11. Choi YK, Adham N, Kiss B, Gyertyán I, Tarazi FI. Long-term effects of aripiprazole exposure on monoaminergic and glutamatergic receptor subtypes: comparison with cariprazine. CNS Spectr. 2017 12; 22(6):484-494. PMID: 28059046.
    Citations: 4     Fields:    
  12. Sahli ZT, Jo J, Mousa SA, Tarazi FI. Clinical management of restless legs syndrome in end-stage renal disease patients. CNS Spectr. 2017 Feb; 22(1):14-21. PMID: 27702420.
    Citations: 1     Fields:    Translation:Humans
  13. Sahli ZT, Banerjee P, Tarazi FI. The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder. Expert Opin Drug Discov. 2016; 11(5):515-23. PMID: 26971593.
    Citations: 1     Fields:    Translation:HumansAnimals
  14. Oosting RS, Chan JS, Olivier B, Banerjee P, Choi YK, Tarazi F. Differential effects of vilazodone versus citalopram and paroxetine on sexual behaviors and serotonin transporter and receptors in male rats. Psychopharmacology (Berl). 2016 Mar; 233(6):1025-34. PMID: 26758283.
    Citations: 3     Fields:    Translation:Animals
  15. Tsapakis EM, Dimopoulou T, Tarazi FI. Clinical management of negative symptoms of schizophrenia: An update. Pharmacol Ther. 2015 Sep; 153:135-47. PMID: 26116809.
    Citations: 9     Fields:    Translation:HumansAnimals
  16. Lopizzo N, Bocchio Chiavetto L, Cattane N, Plazzotta G, Tarazi FI, Pariante CM, Riva MA, Cattaneo A. Gene-environment interaction in major depression: focus on experience-dependent biological systems. Front Psychiatry. 2015; 6:68. PMID: 26005424.
    Citations: 19     
  17. Tarazi FI, Sahli ZT, Pleskow J, Mousa SA. Asperger's syndrome: diagnosis, comorbidity and therapy. Expert Rev Neurother. 2015 Mar; 15(3):281-93. PMID: 25655905.
    Citations: 1     Fields:    Translation:Humans
  18. Tarazi FI, Sahli ZT, Wolny M, Mousa SA. Emerging therapies for Parkinson's disease: from bench to bedside. Pharmacol Ther. 2014 Nov; 144(2):123-33. PMID: 24854598.
    Citations: 18     Fields:    Translation:Humans
  19. Hutson PH, Tarazi FI, Madhoo M, Slawecki C, Patkar AA. Preclinical pharmacology of amphetamine: implications for the treatment of neuropsychiatric disorders. Pharmacol Ther. 2014 Sep; 143(3):253-64. PMID: 24657455.
    Citations: 3     Fields:    Translation:HumansAnimalsCells
  20. Tsapakis EM, Fernandes C, Moran-Gates T, Basu A, Sugden K, Aitchison KJ, Tarazi FI. Effects of antidepressant drug exposure on gene expression in the developing cerebral cortex. Synapse. 2014 May; 68(5):209-20. PMID: 24458505.
    Citations: 3     Fields:    Translation:AnimalsCells
  21. Choi YK, Adham N, Kiss B, Gyertyán I, Tarazi FI. Long-term effects of cariprazine exposure on dopamine receptor subtypes. CNS Spectr. 2014 Jun; 19(3):268-77. PMID: 24229617.
    Citations: 3     Fields:    Translation:AnimalsCells
  22. Tarazi FI, Riva MA. The preclinical profile of lurasidone: clinical relevance for the treatment of schizophrenia. Expert Opin Drug Discov. 2013 Oct; 8(10):1297-307. PMID: 23837554.
    Citations: 4     Fields:    Translation:HumansAnimals
  23. Tayeb HO, Murray ED, Price BH, Tarazi FI. Bapineuzumab and solanezumab for Alzheimer's disease: is the 'amyloid cascade hypothesis' still alive? Expert Opin Biol Ther. 2013 Jul; 13(7):1075-84. PMID: 23574434.
    Citations: 23     Fields:    Translation:HumansAnimals
  24. Tarazi FI, Neill JC. The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania. Expert Opin Drug Discov. 2013 Jan; 8(1):93-103. PMID: 23121334.
    Citations: 7     Fields:    Translation:HumansAnimals
  25. Tarazi FI, Stahl SM. Iloperidone, asenapine and lurasidone: a primer on their current status. Expert Opin Pharmacother. 2012 Sep; 13(13):1911-22. PMID: 22849428.
    Citations: 3     Fields:    Translation:HumansAnimals
  26. Adler LA, Kroon RA, Stein M, Shahid M, Tarazi FI, Szegedi A, Schipper J, Cazorla P. A translational approach to evaluate the efficacy and safety of the novel AMPA receptor positive allosteric modulator org 26576 in adult attention-deficit/hyperactivity disorder. Biol Psychiatry. 2012 Dec 01; 72(11):971-7. PMID: 22771238.
    Citations: 2     Fields:    Translation:HumansAnimals
  27. Bymaster FP, Golembiowska K, Kowalska M, Choi YK, Tarazi FI. Pharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB-1020: implications for treatment of attention-deficit hyperactivity disorder. Synapse. 2012 Jun; 66(6):522-32. PMID: 22298359.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  28. Liégeois JF, Deville M, Dilly S, Lamy C, Mangin F, Résimont M, Tarazi FI. New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation. J Med Chem. 2012 Feb 23; 55(4):1572-82. PMID: 22268448.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  29. Tayeb HO, Yang HD, Price BH, Tarazi FI. Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors. Pharmacol Ther. 2012 Apr; 134(1):8-25. PMID: 22198801.
    Citations: 33     Fields:    Translation:HumansAnimals
  30. Choi YK, Tarazi FI. Alterations in dopamine and glutamate neurotransmission in tetrahydrobiopterin deficient spr-/- mice: relevance to schizophrenia. BMB Rep. 2010 Sep; 43(9):593-8. PMID: 20846490.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  31. Wong EH, Tarazi FI, Shahid M. The effectiveness of multi-target agents in schizophrenia and mood disorders: Relevance of receptor signature to clinical action. Pharmacol Ther. 2010 May; 126(2):173-85. PMID: 20171983.
    Citations: 10     Fields:    Translation:Humans
  32. Ardayfio PA, Leung A, Park J, Hwang DY, Moran-Gates T, Choi YK, Carlezon WA, Tarazi FI, Kim KS. Pitx3-deficient aphakia mice display unique behavioral responses to psychostimulant and antipsychotic drugs. Neuroscience. 2010 Mar 17; 166(2):391-6. PMID: 20026251.
    Citations: 4     Fields:    Translation:AnimalsCells
  33. Tarazi FI, Shahid M. Asenapine maleate: a new drug for the treatment of schizophrenia and bipolar mania. Drugs Today (Barc). 2009 Dec; 45(12):865-76. PMID: 20135021.
    Citations: 3     Fields:    Translation:HumansAnimals
  34. Choi YK, Moran-Gates T, Gardner MP, Tarazi FI. Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats. Eur Neuropsychopharmacol. 2010 Mar; 20(3):187-94. PMID: 19875272.
    Citations: 16     Fields:    Translation:Animals
  35. Choi YK, Wong EH, Henry B, Shahid M, Tarazi FI. Repeated effects of asenapine on adrenergic and cholinergic muscarinic receptors. Int J Neuropsychopharmacol. 2010 Apr; 13(3):405-10. PMID: 19835670.
    Citations: 4     Fields:    Translation:AnimalsCells
  36. Choi YK, Snigdha S, Shahid M, Neill JC, Tarazi FI. Subchronic effects of phencyclidine on dopamine and serotonin receptors: implications for schizophrenia. J Mol Neurosci. 2009 Jul; 38(3):227-35. PMID: 19455435.
    Citations: 15     Fields:    Translation:HumansAnimals
  37. Tarazi FI, Choi YK, Gardner M, Wong EH, Henry B, Shahid M. Asenapine exerts distinctive regional effects on ionotropic glutamate receptor subtypes in rat brain. Synapse. 2009 May; 63(5):413-20. PMID: 19177511.
    Citations: 5     Fields:    Translation:AnimalsCells
  38. Si YG, Choi YK, Gardner MP, Tarazi FI, Baldessarini RJ, Neumeyer JL. Synthesis and neuropharmacological evaluation of esters of R(-)-N-alkyl-11-hydroxy-2-methoxynoraporphines. Bioorg Med Chem Lett. 2009 Jan 01; 19(1):51-3. PMID: 19058967.
    Citations:    Fields:    Translation:AnimalsCells
  39. Choi YK, Gardner MP, Tarazi FI. Effects of risperidone on glutamate receptor subtypes in developing rat brain. Eur Neuropsychopharmacol. 2009 Feb; 19(2):77-84. PMID: 18845422.
    Citations: 17     Fields:    Translation:Animals
  40. Tarazi FI, Moran-Gates T, Wong EH, Henry B, Shahid M. Asenapine induces differential regional effects on serotonin receptor subtypes. J Psychopharmacol. 2010 Mar; 24(3):341-8. PMID: 18719049.
    Citations: 7     Fields:    Translation:Animals
  41. Si YG, Gardner MP, Tarazi FI, Baldessarini RJ, Neumeyer JL. Synthesis and binding studies of 2-O- and 11-O-substituted N-alkylnoraporphines. Bioorg Med Chem Lett. 2008 Jul 15; 18(14):3971-3. PMID: 18585036.
    Citations: 4     Fields:    Translation:AnimalsCells
  42. Tarazi FI, Moran-Gates T, Wong EH, Henry B, Shahid M. Differential regional and dose-related effects of asenapine on dopamine receptor subtypes. Psychopharmacology (Berl). 2008 May; 198(1):103-11. PMID: 18297468.
    Citations: 8     Fields:    Translation:Animals
  43. Si YG, Gardner MP, Tarazi FI, Baldessarini RJ, Neumeyer JL. Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity. J Med Chem. 2008 Feb 28; 51(4):983-7. PMID: 18251489.
    Citations: 4     Fields:    Translation:AnimalsCells
  44. Adrover E, Berger MA, Pérez AA, Tarazi FI, Antonelli MC. Effects of prenatal stress on dopamine D2 receptor asymmetry in rat brain. Synapse. 2007 Jun; 61(6):459-62. PMID: 17372983.
    Citations: 7     Fields:    Translation:Animals
  45. Si YG, Gardner MP, Tarazi FI, Baldessarini RJ, Neumeyer JL. R-(-)-N-alkyl-11-hydroxy-10-hydroxymethyl- and 10-methyl-aporphines as 5-HT1A receptor ligands. Bioorg Med Chem Lett. 2007 Aug 01; 17(15):4128-30. PMID: 17543523.
    Citations: 3     Fields:    Translation:AnimalsCells
  46. Tarazi FI, Moran-Gates T, Gardner MP, Graulich A, Lamy C, Liégeois JF. Long-term effects of JL 13, a potential atypical antipsychotic, on ionotropic glutamate receptors. J Mol Neurosci. 2007; 32(3):192-8. PMID: 17873364.
    Citations: 1     Fields:    Translation:Animals
  47. Moran-Gates T, Grady C, Shik Park Y, Baldessarini RJ, Tarazi FI. Effects of risperidone on dopamine receptor subtypes in developing rat brain. Eur Neuropsychopharmacol. 2007 May-Jun; 17(6-7):448-55. PMID: 17175142.
    Citations: 13     Fields:    Translation:Animals
  48. Tamagnan GD, Brenner E, Alagille D, Staley JK, Haile C, Koren A, Early M, Baldwin RM, Tarazi FI, Baldessarini RJ, Jarkas N, Goodman MM, Seibyl JP. Development of SPECT imaging agents for the norepinephrine transporters: [123I]INER. Bioorg Med Chem Lett. 2007 Jan 15; 17(2):533-7. PMID: 17095215.
    Citations: 3     Fields:    Translation:Animals
  49. Moran-Gates T, Massari C, Graulich A, Liégeois JF, Tarazi FI. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes. J Neurosci Res. 2006 Aug 15; 84(3):675-82. PMID: 16810690.
    Citations: 2     Fields:    Translation:AnimalsCells
  50. Moran-Gates T, Gan L, Park YS, Zhang K, Baldessarini RJ, Tarazi FI. Repeated antipsychotic drug exposure in developing rats: dopamine receptor effects. Synapse. 2006 Feb; 59(2):92-100. PMID: 16270300.
    Citations: 19     Fields:    Translation:Animals
  51. Moran-Gates T, Zhang K, Baldessarini RJ, Tarazi FI. Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol. 2005 Sep; 8(3):439-44. PMID: 15817135.
    Citations: 7     Fields:    Translation:Animals
  52. Hwang DY, Fleming SM, Ardayfio P, Moran-Gates T, Kim H, Tarazi FI, Chesselet MF, Kim KS. 3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease. J Neurosci. 2005 Feb 23; 25(8):2132-7. PMID: 15728853.
    Citations: 60     Fields:    Translation:Animals
  53. Zhang K, Grady CJ, Tsapakis EM, Andersen SL, Tarazi FI, Baldessarini RJ. Regulation of working memory by dopamine D4 receptor in rats. Neuropsychopharmacology. 2004 Sep; 29(9):1648-55. PMID: 15138447.
    Citations: 19     Fields:    Translation:Animals
  54. Tarazi FI, Zhang K, Baldessarini RJ. Dopamine D4 receptors: beyond schizophrenia. J Recept Signal Transduct Res. 2004 Aug; 24(3):131-47. PMID: 15521359.
    Citations: 19     Fields:    Translation:HumansAnimalsCells
  55. Barros VG, Berger MA, Martijena ID, Sarchi MI, Pérez AA, Molina VA, Tarazi FI, Antonelli MC. Early adoption modifies the effects of prenatal stress on dopamine and glutamate receptors in adult rat brain. J Neurosci Res. 2004 May 15; 76(4):488-96. PMID: 15114621.
    Citations: 17     Fields:    Translation:AnimalsCells
  56. Gan L, Falzone TL, Zhang K, Rubinstein M, Baldessarini RJ, Tarazi FI. Enhanced expression of dopamine D(1) and glutamate NMDA receptors in dopamine D(4) receptor knockout mice. J Mol Neurosci. 2004; 22(3):167-78. PMID: 14997010.
    Citations: 17     Fields:    Translation:AnimalsCells
  57. Tarazi FI, Baldessarini RJ, Kula NS, Zhang K. Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: implications for antipsychotic drug treatment. J Pharmacol Exp Ther. 2003 Sep; 306(3):1145-51. PMID: 12829726.
    Citations: 17     Fields:    Translation:Animals
  58. Davids E, Zhang K, Tarazi FI, Baldessarini RJ. Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev. 2003 Apr; 42(1):1-21. PMID: 12668288.
    Citations: 50     Fields:    Translation:Animals
  59. Balcioglu A, Zhang K, Tarazi FI. Dopamine depletion abolishes apomorphine- and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats: a microdialysis study. Neuroscience. 2003; 119(4):1045-53. PMID: 12831863.
    Citations: 11     Fields:    Translation:AnimalsCells
  60. Tarazi FI, Zhang K, Baldessarini RJ. Long-term effects of newer antipsychotic drugs on neuronal nitric oxide synthase in rat brain. Nitric Oxide. 2002 Dec; 7(4):297-300. PMID: 12446179.
    Citations: 2     Fields:    Translation:Animals
  61. Berger MA, Barros VG, Sarchi MI, Tarazi FI, Antonelli MC. Long-term effects of prenatal stress on dopamine and glutamate receptors in adult rat brain. Neurochem Res. 2002 Nov; 27(11):1525-33. PMID: 12512957.
    Citations: 36     Fields:    Translation:Animals
  62. Zhang K, Davids E, Tarazi FI, Baldessarini RJ. Serotonin transporter binding increases in caudate-putamen and nucleus accumbens after neonatal 6-hydroxydopamine lesions in rats: implications for motor hyperactivity. Brain Res Dev Brain Res. 2002 Aug 30; 137(2):135-8. PMID: 12220705.
    Citations: 8     Fields:    Translation:AnimalsCells
  63. Davids E, Hevers W, Dämgen K, Zhang K, Tarazi FI, Lüddens H. Organotypic rat cerebellar slice culture as a model to analyze the molecular pharmacology of GABAA receptors. Eur Neuropsychopharmacol. 2002 Jun; 12(3):201-8. PMID: 12007671.
    Citations: 3     Fields:    Translation:AnimalsCells
  64. Davids E, Zhang K, Kula NS, Tarazi FI, Baldessarini RJ. Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats. J Pharmacol Exp Ther. 2002 Jun; 301(3):1097-102. PMID: 12023542.
    Citations: 23     Fields:    Translation:Animals
  65. Zhang K, Tarazi FI, Davids E, Baldessarini RJ. Plasticity of dopamine D4 receptors in rat forebrain: temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning. Neuropsychopharmacology. 2002 May; 26(5):625-33. PMID: 11927187.
    Citations: 7     Fields:    Translation:Animals
  66. Tarazi FI, Zhang K, Baldessarini RJ. Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions. Psychopharmacology (Berl). 2002 May; 161(3):263-70. PMID: 12021829.
    Citations: 23     Fields:    Translation:AnimalsCells
  67. Zhang K, Davids E, Tarazi FI, Baldessarini RJ. Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions. Psychopharmacology (Berl). 2002 Apr; 161(1):100-6. PMID: 11967637.
    Citations: 7     Fields:    Translation:Animals
  68. Tarsy D, Baldessarini RJ, Tarazi FI. Effects of newer antipsychotics on extrapyramidal function. CNS Drugs. 2002; 16(1):23-45. PMID: 11772117.
    Citations: 49     Fields:    Translation:Humans
  69. Davids E, Zhang K, Tarazi FI, Baldessarini RJ. Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning. Psychopharmacology (Berl). 2002 Feb; 160(1):92-8. PMID: 11862378.
    Citations: 19     Fields:    Translation:Animals
  70. Zhang K, Tarazi FI, Baldessarini RJ. Role of dopamine D(4) receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats. Neuropsychopharmacology. 2001 Nov; 25(5):624-32. PMID: 11682245.
    Citations: 10     Fields:    Translation:Animals
  71. Tarazi FI. Neuropharmacology of dopamine receptors:: Implications in neuropsychiatric diseases. J Sci Res Med Sci. 2001 Oct; 3(2):93-104. PMID: 24019715.
    Citations: 3     
  72. Tarazi FI, Zhang K, Baldessarini RJ. Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment. J Pharmacol Exp Ther. 2001 May; 297(2):711-7. PMID: 11303062.
    Citations: 22     Fields:    Translation:Animals
  73. Zhang K, Tarazi FI, Baldessarini RJ. Nigrostriatal dopaminergic denervation enhances dopamine D(4) receptor binding in rat caudate-putamen. Pharmacol Biochem Behav. 2001 May-Jun; 69(1-2):111-6. PMID: 11420075.
    Citations:    Fields:    Translation:Animals
  74. Tarazi FI, Zhang K, Baldessarini RJ. Effects of nigrostriatal dopamine denervation on ionotropic glutamate receptors in rat caudate-putamen. Brain Res. 2000 Oct 20; 881(1):69-72. PMID: 11033095.
    Citations: 5     Fields:    Translation:Animals
  75. Tarazi FI, Kula NS, Zhang K, Baldessarini RJ. Alkylation of rat dopamine transporters and blockade of dopamine uptake by EEDQ. Neuropharmacology. 2000 Aug 23; 39(11):2133-8. PMID: 10963756.
    Citations:    Fields:    Translation:AnimalsCells
  76. Tarazi FI, Zhang K, Baldessarini RJ. Olanzapine, quetiapine, and risperidone: long-term effects on monoamine transporters in rat forebrain. Neurosci Lett. 2000 Jun 23; 287(2):81-4. PMID: 10854717.
    Citations: 3     Fields:    Translation:Animals
  77. Tarazi FI, Baldessarini RJ. Comparative postnatal development of dopamine D(1), D(2) and D(4) receptors in rat forebrain. Int J Dev Neurosci. 2000 Feb; 18(1):29-37. PMID: 10708903.
    Citations: 94     Fields:    Translation:Animals
  78. Zhang K, Tarazi FI, Baldessarini RJ. Dopamine D(4) receptors in rat forebrain: unchanged with amphetamine-induced behavioral sensitization. Neuroscience. 2000; 97(2):211-3. PMID: 10799752.
    Citations: 1     Fields:    Translation:Animals
  79. Zhang K, Tarazi FI, Campbell A, Baldessarini RJ. GABA(B) receptors: altered coupling to G-proteins in rats sensitized to amphetamine. Neuroscience. 2000; 101(1):5-10. PMID: 11068131.
    Citations: 7     Fields:    Translation:Animals
  80. Kula NS, Baldessarini RJ, Tarazi FI, Fisser R, Wang S, Trometer J, Neumeyer JL. [3H]beta-CIT: a radioligand for dopamine transporters in rat brain tissue. Eur J Pharmacol. 1999 Dec 03; 385(2-3):291-4. PMID: 10607889.
    Citations: 6     Fields:    Translation:AnimalsCells
  81. Zhang K, Weiss NT, Tarazi FI, Kula NS, Baldessarini RJ. Effects of alkylating agents on dopamine D(3) receptors in rat brain: selective protection by dopamine. Brain Res. 1999 Nov 13; 847(1):32-7. PMID: 10564733.
    Citations: 5     Fields:    Translation:Animals
  82. Tarazi FI, Baldessarini RJ. Dopamine D4 receptors: significance for molecular psychiatry at the millennium. Mol Psychiatry. 1999 Nov; 4(6):529-38. PMID: 10578234.
    Citations: 8     Fields:    Translation:Humans
  83. Zhang K, Tarazi FI, Kula NS, Baldessarini RJ, Neumeyer JL. Selective alkylatation of dopamine D2 and D4 receptors in rat brain by N-(p-isothiocyanatophenethyl)spiperone. Neurosci Lett. 1999 Oct 29; 274(3):155-8. PMID: 10548413.
    Citations:    Fields:    Translation:AnimalsCells
  84. Tarazi F, Dvorak MF, Wing PC. Spinal injuries in skiers and snowboarders. Am J Sports Med. 1999 Mar-Apr; 27(2):177-80. PMID: 10102098.
    Citations: 15     Fields:    Translation:Humans
  85. Tarazi FI, Baldessarini RJ. Brain dopamine D(4) receptors: basic and clinical status. Int J Neuropsychopharmacol. 1999 Mar; 2(1):41-58. PMID: 11281970.
    Citations: 4     Fields:    
  86. Tarazi FI, Baldessarini RJ. Regional localization of dopamine and ionotropic glutamate receptor subtypes in striatolimbic brain regions. J Neurosci Res. 1999 Feb 15; 55(4):401-10. PMID: 10723051.
    Citations: 9     Fields:    Translation:AnimalsCells
  87. Kula NS, Tarazi FI, Baldessarini RJ, Xu L, Bakthavachalam V, Pounds S, True CD. Neuropharmacological assessment of potential dopamine D4 receptor-selective radioligands. Eur J Pharmacol. 1999 Feb 12; 367(1):139-42. PMID: 10082277.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  88. Lee H, Tarazi FI, Chakos M, Wu H, Redmond M, Alvir JM, Kinon BJ, Bilder R, Creese I, Lieberman JA. Effects of chronic treatment with typical and atypical antipsychotic drugs on the rat striatum. Life Sci. 1999; 64(18):1595-602. PMID: 10328519.
    Citations: 9     Fields:    Translation:Animals
  89. Tarazi FI, Tomasini EC, Baldessarini RJ. Postnatal development of dopamine D1-like receptors in rat cortical and striatolimbic brain regions: An autoradiographic study. Dev Neurosci. 1999; 21(1):43-9. PMID: 10077701.
    Citations: 48     Fields:    Translation:Animals
  90. Tarazi FI, Campbell A, Baldessarini RJ. Effects of hippocampal kainic acid lesions on striatolimbic dopamine D1-, D2-, and D4-like receptors. Neuroscience. 1998 Nov; 87(1):1-4. PMID: 9722137.
    Citations: 2     Fields:    Translation:Animals
  91. Tarazi FI, Campbell A, Yeghiayan SK, Baldessarini RJ. Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors. Synapse. 1998 Oct; 30(2):227-35. PMID: 9723793.
    Citations: 15     Fields:    Translation:Animals
  92. Tarazi FI, Tomasini EC, Baldessarini RJ. Postnatal development of dopamine D4-like receptors in rat forebrain regions: comparison with D2-like receptors. Brain Res Dev Brain Res. 1998 Oct 01; 110(2):227-33. PMID: 9748595.
    Citations: 33     Fields:    Translation:Animals
  93. Tarazi FI, Tomasini EC, Baldessarini RJ. Postnatal development of dopamine and serotonin transporters in rat caudate-putamen and nucleus accumbens septi. Neurosci Lett. 1998 Sep 18; 254(1):21-4. PMID: 9780082.
    Citations: 52     Fields:    Translation:Animals
  94. Tarazi FI, Campbell A, Baldessarini RJ. Effects of hippocampal lesions on striatolimbic ionotropic glutamatergic receptors. Neurosci Lett. 1998 Jun 26; 250(1):13-6. PMID: 9696054.
    Citations:    Fields:    Translation:Animals
  95. Tarazi FI, Yeghiayan SK, Neumeyer JL, Baldessarini RJ. Medial prefrontal cortical D2 and striatolimbic D4 dopamine receptors: common targets for typical and atypical antipsychotic drugs. Prog Neuropsychopharmacol Biol Psychiatry. 1998 May; 22(4):693-707. PMID: 9682281.
    Citations: 6     Fields:    Translation:Animals
  96. Tarazi FI, Campbell A, Yeghiayan SK, Baldessarini RJ. Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors. Neuroscience. 1998 Mar; 83(1):169-76. PMID: 9466407.
    Citations: 20     Fields:    Translation:AnimalsCells
  97. Tarazi FI, Kula NS, Baldessarini RJ. Regional distribution of dopamine D4 receptors in rat forebrain. Neuroreport. 1997 Nov 10; 8(16):3423-6. PMID: 9427299.
    Citations: 5     Fields:    Translation:Animals
  98. Tarazi FI, Yeghiayan SK, Baldessarini RJ, Kula NS, Neumeyer JL. Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors. Neuropsychopharmacology. 1997 Sep; 17(3):186-96. PMID: 9272485.
    Citations: 4     Fields:    Translation:AnimalsCells
  99. Tarazi FI, Florijn WJ, Creese I. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment. Neuroscience. 1997 Jun; 78(4):985-96. PMID: 9174067.
    Citations: 11     Fields:    Translation:Animals
  100. Florijn WJ, Tarazi FI, Creese I. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs. J Pharmacol Exp Ther. 1997 Feb; 280(2):561-9. PMID: 9023264.
    Citations: 12     Fields:    Translation:AnimalsCells
  101. Tarazi FI, Florijn WJ, Creese I. Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics. Psychopharmacology (Berl). 1996 Dec; 128(4):371-9. PMID: 8986008.
    Citations: 12     Fields:    Translation:Animals
  102. Baldessarini RJ, Tarazi FI. Brain dopamine receptors: a primer on their current status, basic and clinical. Harv Rev Psychiatry. 1996 Mar-Apr; 3(6):301-25. PMID: 9384962.
    Citations: 9     Fields:    Translation:HumansCells
  103. Cascella NG, Tarazi FI, Shirakawa O, Tamminga CA. Savoxepine fails to selectively influence glucose metabolism in the rat limbic system. Psychopharmacology (Berl). 1994 Mar; 114(2):275-80. PMID: 7838920.
    Citations:    Fields:    Translation:Animals
  104. Tarazi FI, Shirakawa O, Tamminga CA. Low dose raclopride spares the extrapyramidal system in rat brain from metabolic effects. Eur J Pharmacol. 1993 Feb 23; 232(1):71-7. PMID: 8096189.
    Citations: 4     Fields:    Translation:Animals
  105. Ghosh TK, Mullaney JM, Tarazi FI, Gill DL. GTP-activated communication between distinct inositol 1,4,5-trisphosphate-sensitive and -insensitive calcium pools. Nature. 1989 Jul 20; 340(6230):236-9. PMID: 2787892.
    Citations: 34     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Tarazi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (363)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.